Ultragenyx Pharmaceutical
RARE
$55.76
Share price
1.20%
Change (1 day)
-15.77%
Change (1 year)
Categories
EPS for Ultragenyx Pharmaceutical (RARE)
EPS in 2023 (TTM): -$15.42
According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$16.16. In 2022 the company made an earnings per share (EPS) of -$15.95 a decrease over its 2021 EPS that were of -$10.59.
EPS history for Ultragenyx Pharmaceutical from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$15.42 | -3.36% |
| 2022 | -$15.95 | 50.67% |
| 2021 | -$10.59 | 113.69% |
| 2020 | -$4.95 | -55.9% |
| 2019 | -$11.23 | 82.56% |
| 2018 | -$6.15 | -45.15% |
| 2017 | -$11.22 | 14.68% |
| 2016 | -$9.78 | 57.36% |
| 2015 | -$6.22 | 69.83% |
| 2014 | -$3.66 | 15.22% |
| 2013 | -$3.18 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $1.23 | -107.60% | 🇺🇸 USA |
 | -$1.01 | -93.75% | 🇺🇸 USA |
 | -$4.45 | -72.46% | 🇺🇸 USA |
 | -$1.07 | -93.36% | 🇺🇸 USA |